Altimmune
ALT
110 hedge funds and large institutions have $467M invested in Altimmune in 2022 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 27 increasing their positions, 31 reducing their positions, and 30 closing their positions.
647% more call options, than puts
Call options by funds: $13.1M | Put options by funds: $1.75M
600% more funds holding in top 10
Funds holding in top 10: 1 → 7 (+6)
125% more capital invested
Capital invested by funds: $207M → $467M (+$260M)
27% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 30
14.47% more ownership
Funds ownership: 77.86% → 92.33% (+14%)
7% more funds holding
Funds holding: 103 → 110 (+7)
13% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$18.5M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$6.33M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$6.19M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$5.8M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$5.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$12.2M |
| 2 |
D.E. Shaw & Co
New York
|
-$4.92M |
| 3 |
State Street
Boston,
Massachusetts
|
-$3.43M |
| 4 |
VA
VR Adviser
New York
|
-$2.41M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$1.82M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GCM
126
Graham Capital Management
Rowayton,
Connecticut
| – | -$63K | -10,345 | Closed |
|
|
JF
127
Jump Financial
Chicago,
Illinois
| – | -$62K | -10,200 | Closed |
|
|
ATC
128
Argent Trust Co
Nashville,
Tennessee
| – | -$61K | -10,000 | Closed |
|
|
AB
129
Amalgamated Bank
New York
| – | -$29K | -4,793 | Closed |
|
|
PHK
130
Point72 Hong Kong
Hong Kong
| – | -$26K | -4,218 | Closed |
|
131
Legal & General Group
London,
United Kingdom
| – | -$19K | -3,166 | Closed |
|
|
AIP
132
Ameritas Investment Partners
Lincoln,
Nebraska
| – | -$19K | -3,098 | Closed |
|
|
MLICM
133
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$17.1K | -2,806 | Closed |
|
134
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$10K | -1,631 | Closed |
|
|
FHA
135
First Horizon Advisors
Memphis,
Tennessee
| – | -$6.38K | -1,035 | -100% |
|
|
EI
136
Ellevest Inc
New York
| – | +$123 | +20 | New |
|
|
CS
137
Credit Suisse
Zurich,
Switzerland
| – | +$130 | +21 | New |
|
ALT Hedge Fund Activity: Q2 2022 in Review
110 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q2 2022, worth a combined $467M — up 125% from $207M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new ALT positions and 30 closed out — a net gain of 8 holders — while 27 added to existing stakes and 31 trimmed.
The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $18.5M. The largest seller was BlackRock, cutting an estimated $12.2M.
- 110 institutional investors held Altimmune (ALT) as of Q2 2022, up from 103 in Q1 2022.
- Funds reported $467M of Altimmune stock for Q2 2022, up 125% quarter-over-quarter.
- 38 funds opened new Altimmune positions in Q2 2022 and 30 closed out, a net change of +8 holders.
- The largest Altimmune buyer in Q2 2022 was Cormorant Asset Management, an estimated $18.5M added.
- The largest Altimmune seller in Q2 2022 was BlackRock, an estimated $12.2M sold.
Based on aggregated 13F filings for Q2 2022.